AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Report Publication Announcement Apr 17, 2024

5328_rns_2024-04-17_246ecde5-43b3-4a38-a20f-180bf3be43a1.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8687K

Spire Healthcare Group PLC

17 April 2024

Spire Healthcare Group plc

('Spire Healthcare', 'the Company' or 'the Group')

Capital Markets Event

17 April 2024

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, will today host a Capital Markets Event at the offices of Instinctif Partners, London, starting at 10.00am.

The event will be led by CEO Justin Ash and involve presentations by senior executives covering the following topics:

·      Hospitals Business deep dive - with a focus on the savings programme announced at the Group's FY23 results and activities to further enhance hospital margins

·      Overview of Spire Occupational Health

·      Introduction to Vita Health Group

The event is open to institutional investors, sell-side analysts and lending banks only. To request a place at the event, please contact Instinctif Partners at [email protected] .

For those who cannot attend in person, the presentation will also be accessible via live Zoom webcast. Click the following link to register in advance for the live Zoom webcast and to receive access details: https://spirehealthcare.zoom.us/webinar/register/WN_oWnMSbVmQGisjIaTqS5MSg

A recording of the webcast will be made available following the event on the Spire Healthcare website, https://www.investors.spirehealthcare.com

No new material information will be disclosed during the event.

The next trading update will be announced in three weeks' time at 7.00am on 9 May 2024, ahead of the Company's AGM, in line with usual practice.

- Ends -

For further information please contact:

Spire Healthcare

Angus Prentice - Director of Investor Relations
+44 (0)7974 982 512
Instinctif Partners

Damian Reece

Guy Scarborough

Jeremy Durrant
+44 (0)7931 598 593

+44 (0)7917 178 920

+44 (0)7792 918 648

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

About Spire Healthcare

Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 39 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good,' 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUNVNRSRUSAAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.